Tpg Gp A, LLC Fusion Pharmaceuticals Inc. Transaction History
Tpg Gp A, LLC
- $4.02 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding FUSN
# of Institutions
6Shares Held
103KCall Options Held
1.4KPut Options Held
0-
Tekla Capital Management LLC43.4KShares$00.01% of portfolio
-
Credit Suisse Ag Zurich, V840.9KShares$00.0% of portfolio
-
Bluefin Capital Management, LLC New York, NY10KShares$00.02% of portfolio
-
Cutler Group LP8.6KShares$00.06% of portfolio
-
American Portfolios Advisors Holbrook, NY30Shares$00.0% of portfolio
About Fusion Pharmaceuticals Inc.
- Ticker FUSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,390,500
- Description
- Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...